The novel founder homozygous V225M mutation in the HSD17B3 gene causes aberrant splicing and XY-DSD
- 5 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 69 (3), 650-654
- https://doi.org/10.1007/s12020-020-02327-z
Abstract
Purpose Mutations in the gene HSD17B3 encoding the 17-beta hydroxysteroid dehydrogenase 3 enzyme cause testosterone insufficiency leading to XY disorders of sex development. In this study the clinical and molecular characteristics of three patients from consanguineous families are elucidated. Methods We identified three patients from two unrelated families with XY DSD and a novel homozygous HSD17B3:c. 673G>A mutation. The effect of the mutation on splicing was determined in RNA extracted from the testis of one patient. Results Three patients presented at ages 0.1, 8 and 0.7 years with ambiguous genitalia and an XY Karyotype. Endocrine workup showed normal cortisol and mineralocorticoid levels with a low testosterone/androstenedione ratio. Whole-exome sequencing, carried out in the first family, revealed a homozygous novel mutation in the HSD17B3 gene: c. 673G>A, p. V225M. The same mutation was found by Sanger sequencing in the third unrelated patient. Haplotype analysis of a 4 Mb region surrounding the HSD17B3 gene on chromosome 9 revealed that the mutation resides on the same allele in all three patients. The mutation, being the first nucleic acid on exon 10, affects splicing and causes exon 10 skipping in one of our patients’ testes. Conclusion The novel homozygous c. 673G>A, p. V225M mutation in the 17HSDB3 gene is likely a founder mutation and causes severe XY-DSD. It changes a conserved amino acid residue, and also alters 17HSDB3 gene transcription by causing skipping of exon 10, thereby contributing to an imbalance in the relevant protein isoforms and consequently, significant decreased 17HDSB3 enzymatic activity.Keywords
This publication has 12 references indexed in Scilit:
- Biochemical Analysis of Four Missense Mutations in the HSD17B3 Gene Associated with 46, XY Disorders of Sex Development in Egyptian PatientsThe Journal of Sexual Medicine, 2017
- Severe Undervirilisation in a 46,XY Case Due to a Novel Mutation in HSD17B3 GeneJournal of Clinical Research in Pediatric Endocrinology, 2015
- Screening for mutations in 17β-hydroxysteroid dehydrogenase and androgen receptor in women presenting with partially virilised 46,XY disorders of sex developmentActa Endocrinologica, 2015
- In silico prediction of splice-altering single nucleotide variants in the human genomeNucleic Acids Research, 2014
- A Novel Nonsense Mutation in HSD17B3 Gene in a Tunisian Patient with Sexual AmbiguityThe Journal of Sexual Medicine, 2013
- 17-β-Hydroxysteroid Dehydrogenase Type 3 Deficiency in Three Adult Iranian SiblingsSexual Development, 2011
- Phenotypic variability in 17β‐hydroxysteroid dehydrogenase‐3 deficiency and diagnostic pitfallsClinical Endocrinology, 2007
- Gas Chromatography-Mass Spectrometry Profiling of Steroids in Times of Molecular BiologyHormone and Metabolic Research, 2004
- Genomic variants in exons and introns: identifying the splicing spoilersNature Reviews Genetics, 2004
- Male Pseudohermaphroditism Due to Testicular 17β-Hydroxysteroid Dehydrogenase Deficiency1Journal of Clinical Endocrinology & Metabolism, 1973